Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease.

[1]  V. Salomaa,et al.  Abdominal obesity is key when evaluating interactions between alcohol use and obesity for liver disease , 2022, Journal of Hepatology.

[2]  D. Mozaffarian,et al.  Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. , 2022, Journal of the American College of Cardiology.

[3]  U. Huber-Schönauer,et al.  Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. , 2022, Journal of hepatology.

[4]  L. Leggio,et al.  Alcohol use disorder in community management of chronic liver diseases , 2022, Hepatology.

[5]  Xian-ping Wu,et al.  Prevalence of metabolic syndrome among the adult population in western China and the association with socioeconomic and individual factors: four cross-sectional studies , 2022, BMJ Open.

[6]  J. Rehm,et al.  Changes in alcohol use during the COVID‐19 pandemic and previous pandemics: A systematic review , 2022, Alcoholism, clinical and experimental research.

[7]  E. Denova-Gutiérrez,et al.  Prevalence of Metabolic Syndrome Among Mexican Adults. , 2022, Metabolic syndrome and related disorders.

[8]  G. Koob,et al.  Alcohol-Related Deaths During the COVID-19 Pandemic. , 2022, JAMA.

[9]  V. Salomaa,et al.  Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting , 2022, Cell metabolism.

[10]  V. Salomaa,et al.  Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score. , 2022, Journal of hepatology.

[11]  A. Kahraman,et al.  Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease , 2022, Journal of clinical medicine.

[12]  E. Guallar,et al.  Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study , 2022, BMC Medicine.

[13]  Audrey Joyce Foka,et al.  Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. , 2022, The Lancet. Child & adolescent health.

[14]  B. Hanratty,et al.  Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis , 2022, BMJ Open.

[15]  V. Wong,et al.  ACE inhibitors prevent liver-related events in non-alcoholic fatty liver disease. , 2021, Hepatology.

[16]  H. El‐Serag,et al.  Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease , 2021, Hepatology.

[17]  R. Antonelli Incalzi,et al.  Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank , 2021, International Journal of Obesity.

[18]  A. Sanyal,et al.  Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis , 2021, JHEP reports : innovation in hepatology.

[19]  A. Luke,et al.  The associations between alcohol intake and cardiometabolic risk in African-origin adults spanning the epidemiologic transition , 2021, BMC Public Health.

[20]  V. de Lédinghen,et al.  Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[21]  D. Thabut,et al.  Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. , 2021, Journal of hepatology.

[22]  V. Salomaa,et al.  Waist and hip circumference are independently associated with the risk of liver disease in population‐based studies , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[23]  P. Hayes,et al.  Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity , 2021, Hepatology.

[24]  P. Charatcharoenwitthaya,et al.  The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis , 2021, Frontiers in Medicine.

[25]  R. Pleijhuis,et al.  Validation and comparison of 28 risk prediction models for coronary artery disease. , 2021, European journal of preventive cardiology.

[26]  Chris S. Pridgeon,et al.  CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload , 2021, International journal of molecular sciences.

[27]  F. Sun,et al.  Alcohol and Metabolic-associated Fatty Liver Disease , 2021, Journal of clinical and translational hepatology.

[28]  A. Singal,et al.  Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. , 2021, JAMA.

[29]  V. Salomaa,et al.  Incidence of liver‐related morbidity and mortality in a population cohort of non‐alcoholic fatty liver disease , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[30]  T. Suvitaival,et al.  Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication , 2021, JHEP reports : innovation in hepatology.

[31]  V. Salomaa,et al.  Alcohol Intake and Total Mortality in 142,960 Individuals from the MORGAM Project: a population-based study. , 2021, Addiction.

[32]  R. Antonelli-Incalzi,et al.  A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  G. Pera,et al.  Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[34]  F. Pattou,et al.  Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease. , 2020, Gastroenterology.

[35]  B. Schnabl,et al.  Gut dysbiosis as a driver in alcohol-induced liver injury , 2020, JHEP reports : innovation in hepatology.

[36]  Mary E. Haas,et al.  Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study. , 2020, Gastroenterology.

[37]  D. Böhning,et al.  The combined effect of alcohol and body mass index on risk of chronic liver disease: A systematic review and meta‐analysis of cohort studies , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[38]  P. Muriel,et al.  Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver , 2020, Antioxidants.

[39]  M. Thiele,et al.  Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[40]  M. Ekstedt,et al.  Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus. , 2020, Metabolism: Clinical and Experimental.

[41]  E. Benjamin,et al.  Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study , 2020, Hepatology.

[42]  S. Rajaa,et al.  Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis , 2020, PloS one.

[43]  J. Whitfield,et al.  Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. , 2020, The American journal of gastroenterology.

[44]  A. Kulkarni,et al.  Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities , 2020, Frontiers in Medicine.

[45]  V. Salomaa,et al.  Links between gut microbiome composition and fatty liver disease in a large population sample , 2020, medRxiv.

[46]  B. Schnabl,et al.  Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. , 2020, Cell host & microbe.

[47]  N. Stefan.  Causes, consequences, and treatment of metabolically unhealthy fat distribution. , 2020, The lancet. Diabetes & endocrinology.

[48]  O. Cummings,et al.  ADH1B*2 is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. , 2020, Gastroenterology.

[49]  B. Hanratty,et al.  Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies , 2020, PLoS medicine.

[50]  V. Salomaa,et al.  Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  J. Ludvigsson,et al.  Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. , 2020, The New England journal of medicine.

[52]  Jing Yuan,et al.  Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non‐alcoholic fatty liver disease , 2020, Journal of gastroenterology and hepatology.

[53]  J. Bosch,et al.  Cirrhosis as new indication for statins , 2020, Gut.

[54]  S. Asch,et al.  Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease , 2020, Hepatology.

[55]  V. Salomaa,et al.  Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow‐Up of Population Cohorts , 2020, Hepatology.

[56]  J. Y. Kim,et al.  Identification of metabolic syndrome using phenotypes consisting of triglyceride levels with anthropometric indices in Korean adults , 2020, BMC Endocrine Disorders.

[57]  M. Färkkilä,et al.  Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions , 2020, Seminars in Liver Disease.

[58]  H. Scharnagl,et al.  HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. , 2020, Journal of hepatology.

[59]  V. Salomaa,et al.  Genetic and lifestyle risk factors for advanced liver disease among men and women , 2020, Journal of gastroenterology and hepatology.

[60]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[61]  K. Abeysekera,et al.  Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study , 2020, The lancet. Gastroenterology & hepatology.

[62]  A. Sanyal,et al.  Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease. , 2020, Cell metabolism.

[63]  S. Sookoian,et al.  Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease , 2020, Gut.

[64]  D. Crabb,et al.  Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases , 2020, Hepatology.

[65]  M. Färkkilä,et al.  Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies. , 2019, Alcoholism, clinical and experimental research.

[66]  S. Gudbjörnsdottir,et al.  Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[67]  J. Rehm,et al.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. , 2019, The American journal of gastroenterology.

[68]  V. Wong,et al.  Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[69]  C. Weston,et al.  Obesity in acute alcoholic hepatitis increases morbidity and mortality , 2019, EBioMedicine.

[70]  Ning Wang,et al.  Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease , 2019, Front. Immunol..

[71]  N. Sattar,et al.  Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts , 2019, BMC Medicine.

[72]  Fuwei Yang,et al.  Metabolic syndrome and liver-related events: a systematic review and meta-analysis , 2019, BMC Endocrine Disorders.

[73]  D. Kang,et al.  Association between Change in Alcohol Consumption and Metabolic Syndrome: Analysis from the Health Examinees Study , 2019, Diabetes & metabolism journal.

[74]  V. Salomaa,et al.  THU-251-Metabolic risk factors for advanced liver disease among alcohol risk users in the general population , 2019, Journal of Hepatology.

[75]  Zhengming Chen,et al.  Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people , 2019, International journal of cancer.

[76]  S. Sookoian,et al.  Review article: shared disease mechanisms between non‐alcoholic fatty liver disease and metabolic syndrome – translating knowledge from systems biology to the bedside , 2019, Alimentary pharmacology & therapeutics.

[77]  M. Longo,et al.  Genetic and Epigenetic Modifiers of Alcoholic Liver Disease , 2018, International journal of molecular sciences.

[78]  A. McCullough,et al.  Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study , 2018, Hepatology.

[79]  Dan J Stein,et al.  Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[80]  M. Kumar,et al.  Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[81]  J. Lazarus,et al.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.

[82]  E. Park,et al.  Alcohol consumption frequency or alcohol intake per drinking session: Which has a larger impact on the metabolic syndrome and its components? , 2018, Alcohol.

[83]  Antonio Felix Conde-Martin,et al.  Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. , 2018, Gastroenterology.

[84]  D. Tousoulis,et al.  Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? , 2018, European journal of gastroenterology & hepatology.

[85]  A. Ferrari,et al.  Global statistics on alcohol, tobacco and illicit drug use: 2017 status report , 2018, Addiction.

[86]  A. Jula,et al.  Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population , 2018, Hepatology.

[87]  William J. Astle,et al.  Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies , 2018, The Lancet.

[88]  N. Tanaka,et al.  Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis , 2018, World journal of gastroenterology.

[89]  T. Turin,et al.  Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies , 2018, BMC Public Health.

[90]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[91]  Q. Anstee,et al.  The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. , 2018, Journal of hepatology.

[92]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[93]  A. Jula,et al.  Binge drinking and the risk of liver events: A population‐based cohort study , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[94]  A. Carlsson,et al.  Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population‐based Cohort Study , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[95]  F. Åberg,et al.  Interpreting lipoproteins in nonalcoholic fatty liver disease , 2017, Current opinion in lipidology.

[96]  M. Severo,et al.  The prevalence of the metabolic syndrome in Portugal: the PORMETS study , 2017, BMC Public Health.

[97]  Kyu Bong Cho,et al.  Association Between Alcohol Consumption and Metabolic Syndrome in a Community-Based Cohort of Korean Adults , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[98]  Stefan Neubauer,et al.  Characterisation of liver fat in the UK Biobank cohort , 2017, PloS one.

[99]  J. Rehm,et al.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.

[100]  S. Lai,et al.  Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance , 2016, The Journal of clinical endocrinology and metabolism.

[101]  S. Sookoian,et al.  Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease , 2016, Alimentary pharmacology & therapeutics.

[102]  L. Chambless,et al.  Timing and Type of Alcohol Consumption and the Metabolic Syndrome - ELSA-Brasil , 2016, PloS one.

[103]  T. Chikritzhs,et al.  Alcohol: taking a population perspective , 2016, Nature Reviews Gastroenterology &Hepatology.

[104]  K. Humphreys,et al.  Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. , 2016, Addiction.

[105]  S. Sookoian,et al.  How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals? , 2016, Gastroenterology.

[106]  B. Graubard,et al.  Population attributable fractions of risk factors for hepatocellular carcinoma in the United States , 2016, Cancer.

[107]  Yoshiyuki Suzuki,et al.  Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[108]  Alexis M. Kalergis,et al.  Innate Immunity and Inflammation in NAFLD/NASH , 2016, Digestive Diseases and Sciences.

[109]  G. Davey Smith,et al.  Alcohol intake and cardiovascular risk factors: A Mendelian randomisation study , 2015, Scientific Reports.

[110]  Milagros Rojas,et al.  Relationship between Alcohol Consumption and Components of the Metabolic Syndrome in Adult Population from Maracaibo City, Venezuela , 2015, Advances in preventive medicine.

[111]  Tao Zhang,et al.  Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population , 2015, BMJ Open.

[112]  S. Bell,et al.  Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies , 2015, Diabetes Care.

[113]  Josivan G. Lima,et al.  Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. , 2015 .

[114]  Henry Völzke,et al.  Metabolic syndrome across Europe: Different clusters of risk factors , 2015, European journal of preventive cardiology.

[115]  Min Zhang,et al.  Association of alcohol consumption and components of metabolic syndrome among people in rural China , 2015, Nutrition & Metabolism.

[116]  T. Arisawa,et al.  Binge Alcohol Consumption Aggravates Oxidative Stress and Promotes Pathogenesis of NASH from Obesity-Induced Simple Steatosis , 2014, Molecular medicine.

[117]  Hynek Pikhart,et al.  Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data , 2014, BMJ : British Medical Journal.

[118]  E. Feskens,et al.  Combined Effects of Smoking and Alcohol on Metabolic Syndrome: The LifeLines Cohort Study , 2014, PloS one.

[119]  S. Robson,et al.  Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study , 2014, PloS one.

[120]  S. Sookoian,et al.  Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals , 2013, Gut.

[121]  M. Murad,et al.  Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.

[122]  S. Sookoian,et al.  Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease , 2013, PloS one.

[123]  P Boffetta,et al.  Metabolic syndrome and hepatocellular carcinoma risk , 2012, British Journal of Cancer.

[124]  F. Messerli,et al.  Alcohol Consumption and the Risk of Hypertension in Men and Women: A Systematic Review and Meta‐Analysis , 2012, Journal of clinical hypertension.

[125]  Jianjun Luo,et al.  Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. , 2012, European journal of cancer.

[126]  P. Stattin,et al.  Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults , 2012, International journal of cancer.

[127]  Qiwen Ben,et al.  Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studies , 2012, International journal of cancer.

[128]  A. Lugea,et al.  Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. , 2011, Journal of hepatology.

[129]  M. Martínez-González,et al.  Alcohol consumption and body weight: a systematic review. , 2011, Nutrition reviews.

[130]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[131]  S. Friedman,et al.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis , 2010, Fibrogenesis & tissue repair.

[132]  I. Wakabayashi.  Cross-sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women. , 2010, Journal of atherosclerosis and thrombosis.

[133]  M. Stepanova,et al.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study , 2010, Gut.

[134]  S. Costanzo,et al.  Contemporary Reviews in Cardiovascular Medicine Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease , 2010 .

[135]  P. Mandrekar,et al.  Signalling pathways in alcohol-induced liver inflammation. , 2009, Journal of hepatology.

[136]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[137]  M. Holmqvist,et al.  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease , 2009, Scandinavian journal of gastroenterology.

[138]  A. Mokdad,et al.  Patterns of alcohol consumption and the metabolic syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[139]  C. Shin,et al.  Prospective study of alcohol consumption and metabolic syndrome. , 2008, The American journal of clinical nutrition.

[140]  Jian-Gao Fan,et al.  Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation. , 2008, World journal of gastroenterology.

[141]  Licia Iacoviello,et al.  Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. , 2006, Archives of internal medicine.

[142]  J. Rohrer,et al.  Patterns of alcohol drinking and its association with obesity: data from the third national health and nutrition examination survey, 1988–1994 , 2005, BMC public health.

[143]  R. Vasan,et al.  Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[144]  Robert J Glynn,et al.  Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.

[145]  T. Risby,et al.  Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.

[146]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[147]  B. Gao,et al.  Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations , 2018, Nature Reviews Gastroenterology & Hepatology.

[148]  Y. Arase,et al.  Relationship between Alcohol Intake and Risk Factors for Metabolic Syndrome in Men. , 2015, Internal medicine.

[149]  S. Sakaguchi,et al.  Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. , 2011, Drug metabolism and pharmacokinetics.

[150]  George Davey Smith,et al.  Supplementary Table S1 , 2008 .

[151]  N. Weiss,et al.  Is central obesity associated with cirrhosis-related death or hospitalization? A population-based, cohort study. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[152]  C. Byrne,et al.  Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes , 2005, Diabetologia.